Global Pediatric Interventional Cardiology Market size, share, Growth & Trends Analysis Report by Devices (Heart Defect Closure Devices, Transcatheter Heart Valves and others) and Region-Market Intelligence & Forecast, 2019-2026
Date: Dec-2019 | Id: MACRC-1187 | Geographical Scope: Global | Publisher: MACRC
Global Pediatric Interventional Cardiology Market size, share, Growth & Trends Analysis Report by Devices (Heart Defect Closure Devices, Transcatheter Heart Valves and others) and Region-Market Intelligence & Forecast, 2019-2026 “Global Pediatric Interventional Cardiology Market was valued at USD 1,580.20 Million in the year 2015 and is expected to reach approximately USD 2,515.17 Million by 2026, at CAGR 5.30% from 2019 to 2026.” Introduction From last decade, there have been major technological achievement in pediatric interventional cardiology such as cardiac imaging, computed tomography, magnetic resonance imaging, especially in 3-dimensional imaging of echocardiography, and cineangiography. Therefore, various types of congenital heart diseases can be treated in the cardiac catheter laboratory. Furthermore, lesions previously considered resistant to interventional therapies can now be managed with high success rates. The Global pediatric interventional cardiology market is segmented on the basis of application and region. On the basis of application the market is fragmented into heart defect closure devices, transcatheter heart valves and others. The transcatheter heart valves segment is futher segmented into transcatheter pulmonary valves and transcatheter aortic valves. The transcatheter heart valves segment has accounted highest highest market share in 2017. The others segment consist of devices such as guidewires, stents, catheters, and balloons. Market Dynamics The key drivers expected to fuel the pediatric interventional cardiology market demand are the growing incidences of congenital heart conditions among pediatric patients. In addition, initiatives taken by regulatory authorities to reinforce the interventional cardiology segment and growing expenditure by market participants for the R&D of novel heart valve products. However, high initial setup cost and presence of stringent regulatory environment are hindering the market growth. The global pediatric interventional cardiology market is expected significant growth during the forecast period due to the growing population base of pediatric patients and development of novel minimally invasive devices. The increasing adoption rate, rising incidences of congenital anomalies, and rising awareness are the key factors to drive the growth of pediatric interventional cardiology market in coming years. Geographical Outlook Geographically, the shares of generated revenue from the pediatric interventional cardiology market are divided into North America, Europe, Asia Pacific and RoW. North America accounted for the largest share in 2017 owing to ongoing R&D programs developing novel pulmonary & aortic heart valves by using decellularized matrices are fueling the demand of this market in this region. Moreover, this developments are combined with DA initiatives to strengthen the interventional cardiology regulatory framework which is propelling the growth of this market in North America region. The Asia Pacific region is expected to grow at a highest CAGR due to the increasing government investments in cardiology and also growth of medical tourism. The pediatric interventional cardiology market is highly oligopolistic, consolidated, and competitive. Market Segmentation On the Basis of Devices • Heart Defect Closure Devices • Transcatheter Heart Valves • Others Key Players Some of the key players operating in the global pediatric interventional cardiology market are Gore Medical, Medtronic, Inc., Boston Scientific Corporation, GE Healthcare, Siemens Healthcare, Abbott Vascular, Cordis Corporation, St. Jude Medical, Numed, Inc., Toshiba Corporation and others. Key questions addresses by the report: a) What are the key trends and dynamics existing in the market? b) What are the emerging trends? c) What are the global opportunities in the pediatric interventional cardiology market? d) Who are the major market players in the pediatric interventional cardiology market? e) How competitive is the market? f) What are the growth trends and the largest revenue-generating region for pediatric interventional cardiology market? g) Which geographical region is holding major potential for new entrants?
TABLE OF CONTENTS Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources 1.4. List of Abbreviations Chapter 2. Executive Summary 2.1. Pediatric Interventional Cardiology Market - Industry Snapshot 2.2. Pediatric Interventional Cardiology Market Chapter 3. Customer Care BPO Industry Outlook 3.1. Market Segmentation 3.2. Value Chain Analysis 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.3.3. Market opportunity analysis 3.4. Penetration & Growth Prospects Mapping 3.5. Industry Analysis - Porter’s Five Forces Analysis 3.6. PESTEL Analysis Chapter 4. Pediatric Interventional Cardiology Market: By Devices (USD Million) 4.1. Heart Defect Closure Devices 4.2. Transcatheter Heart Valves 4.3 Others Chapter 5. Pediatric Interventional Cardiology Market: Regional Outlook 5.1. Pediatric Interventional Cardiology Market Estimates & Forecasts 5.2. North America 5.2.1. Market estimates and forecasts 5.2.2. Market estimates and forecasts, By Devices 5.2.3. U.S. 5.2.3.1. Market estimates and forecasts 5.2.3.2. Market estimates and forecasts, By Devices 5.2.4. Canada 5.2.4.1. Market estimates and forecasts 5.2.4.2. Market estimates and forecasts, By Devices 5.3. Europe 5.3.1. Market estimates and forecasts 5.3.2. Market estimates and forecasts, By Devices 5.3.3. U.K. 5.3.3.1. Market estimates and forecasts 5.3.3.2. Market estimates and forecasts, By Devices 5.3.4. Germany 5.3.4.1. Market estimates and forecasts 5.3.4.2. Market estimates and forecasts, By Devices 5.3.5. France 5.3.5.1. Market estimates and forecasts 5.3.5.2. Market estimates and forecasts, By Devices 5.4. Asia Pacific 5.4.1. Market estimates and forecasts 5.4.2. Market estimates and forecasts, By Devices 5.4.3. China 5.4.3.1. Market estimates and forecasts 5.4.3.2. Market estimates and forecasts, By Devices 5.4.4. India 5.4.4.1. Market estimates and forecasts 5.4.4.2. Market estimates and forecasts, By Devices 5.4.5. Japan 5.4.5.1. Market estimates and forecasts 5.4.5.2. Market estimates and forecasts, By Devices 5.4.6. Singapore 5.4.6.1. Market estimates and forecasts 5.4.6.2. Market estimates and forecasts, By Devices 5.5. Latin America 5.5.1. Market estimates and forecasts 5.5.2. Market estimates and forecasts, By Devices 5.5.3. Brazil 5.5.3.1. Market estimates and forecasts 5.5.3.2. Market estimates and forecasts, By Devices 5.6.5. Mexico 5.6.5.1. Market estimates and forecasts 5.6.5.2. Market estimates and forecasts, By Devices 5.6. Middle East & Africa 5.6.1. Market estimates and forecasts 5.6.2. Market estimates and forecasts, By Devices Chapter 6. Competitive Landscape 6.1. Gore Medical 6.1.1. Company overview 6.1.2. Financial performance 6.1.3. Product benchmarking 6.1.4. Recent developments 6.2. Boston Scientific Corporation 6.2.1. Company overview 6.2.2. Financial performance 6.2.3. Product benchmarking 6.2.4. Recent developments 6.3. Medtronic, Inc. 6.3.1. Company overview 6.3.2. Financial performance 6.3.3. Product benchmarking 6.3.4. Recent developments 6.4. Cordis Corporation 6.4.1. Company overview 6.4.2. Financial performance 6.4.3. Product benchmarking 6.4.4. Recent developments 6.5. St. Jude Medical 6.5.1. Company overview 6.5.2. Financial performance 6.5.3. Product benchmarking 6.5.4. Recent developments 6.6. Abbott Vascular 6.6.1. Company overview 6.6.2. Financial performance 6.6.3. Product benchmarking 6.6.4. Recent developments 6.7 Numed, Inc. 6.7.1. Company overview 6.7.2. Financial performance 6.7.3. Product benchmarking 6.7.4. Recent developments 6.8. GE Healthcare 6.8.1. Company overview 6.8.2. Financial performance 6.8.3. Product benchmarking 6.8.4. Recent developments 6.9. Siemens Healthcare 6.9.1. Company overview 6.9.2. Financial performance 6.9.3. Product benchmarking 6.9.4. Recent developments 6.10. Toshiba Corporation 6.10.1. Company overview 6.10.2. Financial performance 6.10.3. Product benchmarking 6.10.4. Recent developments
Related reports
Global IVD Market
$2640-$4521
Pediatric Interventional Cardiology Market
$2640-$4521